
    
      Both gender patients presenting Miller class I or II recession defects >4mm were selected.
      Patients were randomly assigned to treatment groups: newly forming bone graft (NFBG) or
      subepithelial connective tissue graft (SCT). Patients were treated in the period of February
      2008 and March 2008 and monitored during 9 months.
    
  